Novavax (NVAX) Return on Capital Employed Growth (1y) (2012 - 2026)
Novavax (NVAX) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
31,429.00 |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
16,829.00 |
| 10 |
Novavax |
1.49 Bn |
931.98 Mn |
108.82 Mn |
-5,114.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-5,114.00 |
| Dec 31, 2025 |
11,468.00 |
| Sep 30, 2025 |
8,868.00 |
| Jun 30, 2025 |
10,639.00 |
| Mar 31, 2025 |
9,264.00 |
| Dec 31, 2024 |
56,289.00 |
| Sep 30, 2024 |
25,796.00 |
| Jun 30, 2024 |
349,817.00 |
| Mar 31, 2024 |
-647,359.00 |
| Dec 31, 2023 |
-94,200.00 |
| Sep 30, 2023 |
-15,181.00 |
| Jun 30, 2023 |
-332,112.00 |
| Mar 31, 2023 |
670,712.00 |
| Dec 31, 2022 |
125,913.00 |
| Sep 30, 2022 |
-4,222.00 |
| Jun 30, 2022 |
-15,483.00 |
| Mar 31, 2022 |
-21,728.00 |
| Dec 31, 2021 |
-87,070.00 |
| Sep 30, 2021 |
-7,792.00 |
| Jun 30, 2021 |
-7,058.00 |
